Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PEN · against 1,336 other Healthcare companies
Ranked #783 of 1,337 · scores higher than 41% of peers
Bars: peers in each 10-point band of the valuation score134 peers with a valuation score of 40–49, including PEN · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | PEN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 1,287 reported | 1.3% | 1.5% | 48% | 30% | |
| EBITDA yieldHigher is better · 1,357 reported | 1.7% | 4.2% | 38% | 50% | |
| Free cash flow yieldHigher is better · 711 reported | 1.7% | -1.0% | 60% | 20% | |
| Book yieldHigher is better · 1,306 reported | 12.1% | 37.9% | 17% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.3B HKD (≈$2.7B) | 99 | 68 | |
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 783 | 593.2B INR (≈$7.1B) | 41 | 47 | |
| 783 | 13.2B USD | 41 | 30 | |
| 783 | 10.8B USD | 41 | 41 | |
| 783 | 449M USD | 41 | 72 | |
| 783 | 12.6B USD | 41 | 65 | |
| 783 | 639M AUD (≈$422M) | 41 | 55 | |
| 783 | 1.6B USD | 41 | 29 | |
| 783 | 2.1B USD | 41 | 61 | |
| 796 | 2.6B CNY (≈$359M) | 40 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score